261 related articles for article (PubMed ID: 17407365)
1. Serotonin reuptake inhibitor-induced perinatal complications.
Gentile S
Paediatr Drugs; 2007; 9(2):97-106. PubMed ID: 17407365
[TBL] [Abstract][Full Text] [Related]
2. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.
Moses-Kolko EL; Bogen D; Perel J; Bregar A; Uhl K; Levin B; Wisner KL
JAMA; 2005 May; 293(19):2372-83. PubMed ID: 15900008
[TBL] [Abstract][Full Text] [Related]
3. Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors.
Smith MV; Sung A; Shah B; Mayes L; Klein DS; Yonkers KA
Early Hum Dev; 2013 Feb; 89(2):81-6. PubMed ID: 22999988
[TBL] [Abstract][Full Text] [Related]
4. Paediatric outcomes following intrauterine exposure to serotonin reuptake inhibitors: a systematic review.
Fenger-Grøn J; Thomsen M; Andersen KS; Nielsen RG
Dan Med Bull; 2011 Sep; 58(9):A4303. PubMed ID: 21893008
[TBL] [Abstract][Full Text] [Related]
5. Mother-infant antidepressant concentrations, maternal depression, and perinatal events.
Sit D; Perel JM; Wisniewski SR; Helsel JC; Luther JF; Wisner KL
J Clin Psychiatry; 2011 Jul; 72(7):994-1001. PubMed ID: 21824458
[TBL] [Abstract][Full Text] [Related]
6. [Selective serotonin reuptake inhibitors and pregnancy].
Hassanzadeh T; Pedersen LH; Videbech P
Ugeskr Laeger; 2014 Feb; 176(3):236-9. PubMed ID: 24629751
[TBL] [Abstract][Full Text] [Related]
7. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
[TBL] [Abstract][Full Text] [Related]
8. On categorizing gestational, birth, and neonatal complications following late pregnancy exposure to antidepressants: the prenatal antidepressant exposure syndrome.
Gentile S
CNS Spectr; 2010 Mar; 15(3):167-85. PubMed ID: 20414166
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
10. The effect of perinatal exposures on the infant: antidepressants and depression.
Hanley GE; Oberlander TF
Best Pract Res Clin Obstet Gynaecol; 2014 Jan; 28(1):37-48. PubMed ID: 24100223
[TBL] [Abstract][Full Text] [Related]
11. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H
Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202
[TBL] [Abstract][Full Text] [Related]
12. A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health.
Warburton W; Hertzman C; Oberlander TF
Acta Psychiatr Scand; 2010 Jun; 121(6):471-9. PubMed ID: 19878137
[TBL] [Abstract][Full Text] [Related]
13. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.
Ng QX; Venkatanarayanan N; Ho CYX; Sim WS; Lim DY; Yeo WS
J Womens Health (Larchmt); 2019 Mar; 28(3):331-338. PubMed ID: 30407100
[TBL] [Abstract][Full Text] [Related]
14. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
Singal D; Brownell M; Chateau D; Ruth C; Katz LY
BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
[TBL] [Abstract][Full Text] [Related]
15. Neonate characteristics after maternal use of antidepressants in late pregnancy.
Källén B
Arch Pediatr Adolesc Med; 2004 Apr; 158(4):312-6. PubMed ID: 15066868
[TBL] [Abstract][Full Text] [Related]
16. Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect.
Hanley GE; Brain U; Oberlander TF
Early Hum Dev; 2013 Aug; 89(8):519-24. PubMed ID: 23384962
[TBL] [Abstract][Full Text] [Related]
17. Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes.
Santucci AK; Singer LT; Wisniewski SR; Luther JF; Eng HF; Dills JL; Sit DK; Hanusa BH; Wisner KL
J Clin Psychiatry; 2014 Oct; 75(10):1088-95. PubMed ID: 25373117
[TBL] [Abstract][Full Text] [Related]
18. Neonatal morbidity due to maternal use of two antidepressant drugs.
Jwa S; Wada Y; Yamamoto M; Sumida Y
Pediatr Int; 2018 Jan; 60(1):87-88. PubMed ID: 29235219
[No Abstract] [Full Text] [Related]
19. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.
Sie SD; Wennink JM; van Driel JJ; te Winkel AG; Boer K; Casteelen G; van Weissenbruch MM
Arch Dis Child Fetal Neonatal Ed; 2012 Nov; 97(6):F472-6. PubMed ID: 23080479
[TBL] [Abstract][Full Text] [Related]
20. Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.
Yang A; Ciolino JD; Pinheiro E; Rasmussen-Torvik LJ; Sit DKY; Wisner KL
J Clin Psychiatry; 2017 May; 78(5):605-611. PubMed ID: 28570796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
